{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:39:22Z","timestamp":1788925162776,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bbmt.2014.03.027","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T12:16:36Z","timestamp":1396268196000},"page":"1026-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study"],"prefix":"10.1016","volume":"20","author":[{"given":"Massimo","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicetto","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Scortechini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Marktel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cimminiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Irrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Offidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Console","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Massimo","family":"Lemoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.03.027_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A\u00a0prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.03.027_bib2","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.03.027_bib3","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1182\/blood-2011-06-358812","article-title":"Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)","volume":"118","author":"Palumbo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.027_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/18715206113136660357","article-title":"Autologous stem cell transplantation as a care option in elderly patients. A review","volume":"13","author":"Fratino","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bbmt.2014.03.027_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/07357907.2013.840382","article-title":"Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials","volume":"31","author":"Yaqub","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bbmt.2014.03.027_bib6","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1200\/JCO.2012.48.4626","article-title":"Bortezomib-based versus non bortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials","volume":"31","author":"Sonneveld","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib7","doi-asserted-by":"crossref","first-page":"906247","DOI":"10.1155\/2012\/906247","article-title":"Lenalidomide in the treatment of young patients with multiple myeloma: from induction to consolidation\/maintenance therapy","volume":"2012","author":"Lupo","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib8","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1182\/blood-2012-11-464503","article-title":"Nordic Myeloma Study Group. Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial","volume":"121","author":"Mellqvist","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.027_bib9","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","article-title":"IFM Investigators. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma","volume":"366","author":"Attal","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.03.027_bib10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","article-title":"Lenalidomide after stem-cell transplantation for multiple myeloma","volume":"366","author":"McCarthy","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.03.027_bib11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2010.32.5878","article-title":"Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies","volume":"29","author":"Moreau","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbmt.2013.08.002","article-title":"Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma","volume":"19","author":"Costa","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib13","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3109\/10428194.2012.751528","article-title":"Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma","volume":"54","author":"Dunavin","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2014.03.027_bib14","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2011-02-297325","article-title":"International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation","volume":"117","author":"Cavo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.027_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MOH.0b013e328364f573","article-title":"Hematopoietic stem cell transplantation activity in Europe","volume":"20","author":"Gratwohl","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/bmt.2011.126","article-title":"Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs","volume":"47","author":"Faucher","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/14712598.2012.707185","article-title":"Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program","volume":"12","author":"Martino","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bbmt.2014.03.027_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbmt.2012.12.006","article-title":"Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib19","article-title":"Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma","author":"Scortechini","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2014.03.027_bib20","series-title":"Handbook of biological statistics","first-page":"15","author":"McDonald","year":"2009"},{"key":"10.1016\/j.bbmt.2014.03.027_bib21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A\u00a0clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2014.03.027_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","article-title":"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant","volume":"102","author":"Blad\u00e9","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib23","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/cncr.20163","article-title":"Clinical practice guidelines for the prevention and treatment of cancer therapy induced oral and gastrointestinal mucositis","volume":"100","author":"Rubenstein","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2014.03.027_bib24","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1200\/JCO.2006.10.2509","article-title":"Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study","volume":"25","author":"Cavo","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bmt.1701639","article-title":"A\u00a0model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation","volume":"23","author":"Barosi","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2257.2003.00512.x","article-title":"Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma","volume":"25","author":"Mishra","year":"2003","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bmt.1701191","article-title":"Reduced charges and costs associated with outpatient autologous stem cell transplantation","volume":"21","author":"Meisenberg","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0140-6736(05)61026-4","article-title":"Forest plots and the interpretation of subgroups","volume":"365","author":"Cuzick","year":"2005","journal-title":"Lancet"},{"issue":"4 Suppl 7","key":"10.1016\/j.bbmt.2014.03.027_bib29","first-page":"25","article-title":"The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer","volume":"21","author":"Peters","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1700900","article-title":"Feasibility and cost effectiveness of outpatient autotransplants in multiple myeloma","volume":"20","author":"Jagannath","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib31","first-page":"1192","article-title":"Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma","volume":"87","author":"Morabito","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.03.027_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.thj.6200349","article-title":"Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma","volume":"5","author":"Ferrara","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.bbmt.2014.03.027_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1537-2995.2007.01073.x","article-title":"Outpatient high-dose melphalan in multiple myeloma patients","volume":"47","author":"Kassar","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2014.03.027_bib34","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4065\/83.10.1131","article-title":"Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative","volume":"83","author":"Gertz","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.bbmt.2014.03.027_bib35","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bbmt.2014.03.027_bib36","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1200\/JCO.2006.06.4238","article-title":"Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies","volume":"24","author":"Fernandez-Aviles","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib37","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2014.03.027_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2146\/ajhp060396","article-title":"Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever","volume":"64","author":"Moores","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bbmt.2014.03.027_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2141.2000.02149.x","article-title":"Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study","volume":"110","author":"Capelli","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.03.027_bib40","first-page":"CD000978","article-title":"Interventions for preventing oral mucositis for patients with cancer receiving treatment","author":"Worthington","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bbmt.2014.03.027_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","article-title":"Amifostine: the first selective-target and broad-spectrum radioprotector","volume":"12","author":"Kouvaris","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bbmt.2014.03.027_bib42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bbmt.2010.11.003","article-title":"A\u00a0phase I trial: dose escalation of melphalan in the \u201cBEAM\u201d regimen using amifostine cytoprotection","volume":"17","author":"Phillips","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.027_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-0012.2011.01532.x","article-title":"Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: can we decide?","volume":"26","author":"Ziakas","year":"2012","journal-title":"Clin Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:47:28Z","timestamp":1761058048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1083879114002006"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.03.027","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}